Fas ligand compositions for treatment of proliferative disorders
CA 2283459 A1 · Owner: St. Elizabeth'S Medical Center Of Boston, Inc. · Inventors: Walsh, Kenneth
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for treating vascular injury, particularly vascular injury resulting from restenosis following angioplasty, and vascular remodeling is provided. The method involves administering to subjects in need of such treatment an effective amount of a Fas ligand molecule.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 26, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 26, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 26, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.